← The Wire
ZLABNasdaq
Zai Lab Ltd
Pharmaceutical Preparations · E9 · CIK 1704292
Zai Lab discovers, develops, and commercializes innovative therapies for oncology, immunology, neuroscience, and infectious disease
red 8-K · 90d
$1.92B
Market cap
$18.41
Last close
+2.3%
1D
-0.4%
5D
945K
Volume
Price · last 39 sessions-13.2%
May 4L $16.48 · H $21.22Jun 29
189
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 17, 20268-KExecutive ChangeMay 21, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KMaterial Agreement · New Debt / ObligationOct 16, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KShareholder VoteJun 18, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 20258-KMaterial Agreement · New Debt / ObligationJan 3, 20258-KMaterial Agreement · Company UpdateNov 15, 2024424B5424B5Nov 15, 2024424B5424B5Nov 13, 20248-KCompany UpdateNov 13, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KMaterial Agreement · New Debt / ObligationJul 9, 20248-KExecutive Change · Shareholder VoteJun 18, 20248-KExecutive Change · Reg FD DisclosureJun 11, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 2024SC 13GSEC SCHEDULE 13GFeb 9, 20248-KMaterial Agreement · New Debt / ObligationFeb 8, 2024SC 13GSEC SCHEDULE 13GFeb 8, 202410-K/A10-K/ADec 22, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KExecutive Change · Reg FD DisclosureJul 6, 20238-KReg FD DisclosureJun 30, 20238-KShareholder Vote · Reg FD DisclosureJun 20, 20238-KCompany UpdateJun 6, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEF 14ADEF 14AApr 28, 20238-KCompany UpdateMar 31, 202310-K10-KMar 1, 20238-KResults of OperationsMar 1, 20238-KExecutive ChangeJan 9, 20238-KCompany UpdateJan 5, 202310-Q10-QNov 9, 20228-KResults of OperationsNov 9, 20228-KExecutive ChangeOct 28, 20228-KMaterial Agreement · Reg FD DisclosureSep 27, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 20228-KExecutive ChangeAug 3, 20228-KExecutive Change · Bylaw AmendmentJun 22, 20228-K/AAuditor ChangeJun 1, 20228-KCompany UpdateMay 31, 2022DEFA14ADEFA14AMay 20, 202210-QFORM 10-QMay 10, 20228-KResults of OperationsMay 10, 2022DEFA14ADEFA14AMay 2, 2022DEF 14ADEF 14AMay 2, 20228-K/AAuditor ChangeMay 2, 20228-KAuditor ChangeApr 21, 20228-KExecutive ChangeApr 1, 20228-KShareholder VoteMar 28, 2022DEFA14ADEFA14AMar 23, 20228-KExecutive ChangeMar 15, 20228-KResults of OperationsMar 1, 2022
Insider Activity
In the 90 days to Mar 17, 2026: 1 insider bought $33K · 5 sold $4.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Gaynor RichardDirector | Buy | 1,731 | $18.91 | $33K |
| Mar 13, 2026 | Amado RafaelSee Remarks | Sell | 2,957 | $18.63 | $55K |
| Mar 13, 2026 | Smiley Joshua LSee Remarks | Sell | 1,966 | $18.63 | $37K |
| Mar 13, 2026 | Chen YajingChief Financial Officer | Sell | 1,703 | $18.63 | $32K |
| Mar 13, 2026 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 1,281 | $18.63 | $24K |
| Mar 11, 2026 | Du YingChairperson & CEO | Sell | 1,067 | $19.08 | $20K |
| Mar 9, 2026 | Du YingChairperson & CEO | Sell | 50,000 | $19.03 | $952K |
| Mar 6, 2026 | Du YingChairperson & CEO | Sell | 50,000 | $19.42 | $971K |
| Mar 5, 2026 | Du YingChairperson & CEO | Sell | 50,000 | $19.22 | $961K |
| Mar 5, 2026 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 15,569 | $19.06 | $297K |
| Mar 4, 2026 | Du YingChairperson & CEO | Sell | 35,710 | $19.32 | $690K |
| Mar 4, 2026 | Du YingChairperson & CEO | Sell | 14,290 | $18.78 | $268K |
| Mar 3, 2026 | Amado RafaelSee Remarks | Sell | 10,000 | $17.38 | $174K |
| Dec 31, 2025 | Amado RafaelSee Remarks | Sell | 10,787 | $17.43 | $188K |
| Dec 16, 2025 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 8,651 | $17.14 | $148K |
| Nov 21, 2025 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 14,328 | $19.78 | $283K |
| Nov 3, 2025 | Chen YajingChief Financial Officer | Sell | 240 | $26.83 | $6K |
| Oct 2, 2025 | Chen YajingChief Financial Officer | Sell | 456 | $34.25 | $16K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance